Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$7.48 Mil
% of Total Estimate Gain
103.93%

ACUTA CAPITAL PARTNERS, LLC's Vaxcyte Inc Holding Summary

As of 2025-03-31, ACUTA CAPITAL PARTNERS, LLC held - shares of Vaxcyte Inc(PCVX), totaling N/A. This investment constitutes 0% of their stock portfolio, and ACUTA CAPITAL PARTNERS, LLC now holds 0% of the outstanding Vaxcyte Inc(PCVX) stock.

The initial trade took place in 2022Q3. And since then ACUTA CAPITAL PARTNERS, LLC has made 5 purchases of PCVX, at an average price of $40.74, for a total of 176,736.00 shares. In addition, there have been 6 sales at an average price of $83.08 for 176,736.00 shares. Based on historical transaction data and PCVX's current price of $36.22, ACUTA CAPITAL PARTNERS, LLC's estimated gain on his PCVX holdings is $7.48 Mil, reflecting a 103.93% gain to date.

ACUTA CAPITAL PARTNERS, LLC PCVX ($36.22) Holding Chart

ACUTA CAPITAL PARTNERS, LLC PCVX ($36.22) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1